NGEN
NervGen Pharma Corp.
NASDAQ: NGEN · HEALTHCARE · BIOTECHNOLOGY
$3.63
-3.20% today
Updated 2026-04-30
Market cap
$311.58M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.45
Dividend yield
—
52W range
$2 – $6
Volume
0.2M
NervGen Pharma Corp. (NGEN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 1
Last 1 quarters
Avg EPS surprise
-200.0%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
When is the next earnings report?
Reporting date
March 31, 2025
Consensus EPS estimate
$-0.05
Fiscal period ending
2025-03-31
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.07 | $-0.27 | -284.2% | — | — |
| 2025-09-30 | $-0.04 | — | — | — | — |
| 2025-06-30 | $-0.05 | — | — | — | — |
| 2025-03-31 | $-0.05 | — | — | — | — |
Frequently asked questions
When does NervGen Pharma Corp. report next earnings?
NervGen Pharma Corp. (NGEN) is scheduled to report earnings on March 31, 2025. The consensus EPS estimate is $-0.05.
Has NervGen Pharma Corp. beaten earnings estimates?
NervGen Pharma Corp. has beaten Wall Street EPS estimates in 0 of its last 1 quarterly reports, with an average EPS surprise of -200.0% over the last 1 quarters.